Business Context and Reporting Period
Company: Gladstone Capital Corporation (GLAD)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2013
Business Overview: Gladstone Capital is a closed-end, non-diversified management investment company operating as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The company invests primarily in debt securities of established small and medium-sized U.S. businesses, with a strategy targeting approximately 95% debt and 5% equity at cost. The portfolio consists of 47 companies across 22 industries.
Key Financial Metrics
| Metric | Six Months Ended Mar 31, 2013 | Six Months Ended Mar 31, 2012 |
|---|---|---|
| Total Investment Income | $18.25 million | $20.32 million |
| Net Investment Income | $9.27 million | $9.63 million |
| Net Realized Gain (Loss) | ($3.02 million) | ($8.21 million) |
| Net Unrealized Gain (Loss) | ($648,000) | ($4.31 million) |
| Net Increase in Net Assets from Operations | $5.60 million | ($2.89 million) |
| Net Asset Value (NAV) per Share | $8.91 | $9.62 |
| Total Assets | $285.43 million | $293.40 million |
| Total Liabilities | $98.28 million | $104.84 million |
| Net Assets | $187.15 million | $188.56 million |
| Cash and Cash Equivalents | $8.82 million | $10.16 million |
| Borrowings (Credit Facility) | $55.40 million (Cost) | $58.80 million (Cost) |
| Asset Coverage Ratio | 300.7% | 292.0% |
Material Changes vs. Prior Period
- Investment Income Decline: Total investment income decreased by 10.2% year-over-year, primarily due to a reduction in the weighted average principal balance of the portfolio ($285.5 million vs. $327.0 million) caused by early payoffs. This was partially offset by an increase in the weighted average yield to 11.6% from 11.1%.
- Expense Reduction: Total expenses net of credits decreased by 15.9% to $8.98 million. This was driven by lower interest expense (due to reduced borrowings and removal of the LIBOR floor) and lower management/incentive fees.
- Realized Losses: Net realized losses improved significantly to $3.02 million from $8.21 million in the prior year. The current period losses were primarily due to the sale of Viapack, Inc. ($2.4 million loss) and the write-off of Access Television Network, Inc. ($0.9 million loss).
- Unrealized Depreciation: Net unrealized depreciation on investments was $2.75 million, a significant improvement from $4.93 million in the prior year. The largest driver of depreciation was Reliable Biopharmaceutical Holdings, Inc. ($7.5 million), partially offset by reversals of prior depreciation on exited positions.
- Portfolio Composition: The portfolio contracted slightly, with 47 companies at period end compared to 55 in the prior year. Non-accrual assets represented 16.4% of the cost basis of debt investments (four companies), compared to 12.1% (eight companies) in the prior year.
Guidance, Outlook, and Risks
- Management Commentary: Management notes that while economic conditions are improving, the environment remains challenging. The company is seeing an increase in new investment opportunities but experienced a net contraction in portfolio size due to nine early payoffs totaling $51.9 million during the period.
- Capital Resources: The company maintains a $137.0 million credit facility with $60.5 million available as of March 31, 2013. In April 2013, the maturity date was extended to January 19, 2016. The company is in compliance with all covenants, including a minimum asset coverage ratio of 200% (actual: 300.7%).
- Distributions: The company declared monthly distributions of $0.07 per common share and $0.1484375 per preferred share for the quarter ended March 31, 2013. For the fiscal year ended September 30, 2012, distributions exceeded earnings, resulting in a partial return of capital.
- Risks and Contingencies:
- Valuation Risk: All investments are valued using Level 3 inputs (unobservable), relying on third-party appraisals (SPSE) or internal models (DCF, liquidity waterfall). Significant unrealized depreciation exists ($93.8 million cumulative).
- Concentration Risk: The five largest investments represent 32.4% of the total portfolio fair value.
- Legislative Risk: Pending legislation could modify the 1940 Act to allow BDCs to increase leverage from 50% to 66.7% of assets, potentially increasing risk.
- Non-Accrual Status: Four portfolio companies are on non-accrual status, representing a significant portion of the debt cost basis.
Key Facts for Investor Verification
- NAV vs. Market Price: Verify the trading price of GLAD relative to the reported NAV of $8.91 per share. As of April 29, 2013, the stock traded at a 5.5% premium to NAV.
- Reliable Biopharmaceutical Holdings: Investigate the $7.5 million unrealized depreciation in this single portfolio company, which was a major driver of the period's losses following a controlling equity acquisition.
- Success Fee Receivables: Note the $12.9 million off-balance sheet success fee receivable on accruing debt securities, which is contingent on future liquidity events and not yet recognized as income.
- Credit Facility Covenants: Confirm continued compliance with the 200% asset coverage ratio and minimum net worth covenants, especially given the portfolio's unrealized depreciation.
- Fee Waivers: Review the impact of the voluntary, irrevocable fee waivers by the Adviser (reducing base management fees on syndicated loans and waiving portions of the incentive fee) on future expense ratios.